Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.04. | Acutus Medical GAAP EPS of -$2.81, revenue of $7.2M | 1 | Seeking Alpha | ||
01.04. | Acutus Medical, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
01.04. | Acutus Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.02. | Acutus Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
11.01. | Acutus Medical, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
14.11.23 | Acutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2M | 3 | Seeking Alpha | ||
10.11.23 | Acutus Medical, Inc.: Acutus Medical to Cancel Third Quarter 2023 Conference Call | 6 | GlobeNewswire (USA) | ||
10.11.23 | Fast Five: Acutus Medical is laying off more than half its workers, 3M Health Care group president is leaving | 18 | MassDevice | ||
09.11.23 | Acutus Medical lays off two-thirds of staff to focus solely on left-heart access deal with Medtronic | 17 | FierceBiotech | ||
09.11.23 | Medtronic's Manufacturing Partner Acutus Medical Exits Electrophysiology Mapping, Ablation Businesses | 10 | Benzinga.com | ||
09.11.23 | Acutus Medical rises after restructuring plans | 4 | Reuters | ||
09.11.23 | Acutus Medical to cut 65% of workforce, focus on Medtronic contracts | 12 | Seeking Alpha | ||
08.11.23 | Acutus Medical is laying off more than half of its workers | 4 | MassDevice | ||
08.11.23 | Acutus Medical, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
08.11.23 | Acutus Medical, Inc.: Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring | 246 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens... ► Artikel lesen | |
08.11.23 | Acutus Medical, Inc.: Acutus Medical Reports Third Quarter 2023 Financial Results | 158 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter... ► Artikel lesen | |
02.11.23 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 139 | GlobeNewswire (Europe) | CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
02.10.23 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 161 | GlobeNewswire (Europe) | CARLSBAD, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
07.08.23 | Acutus Medical, Inc.: Acutus Medical Reports Second Quarter 2023 Financial Results | 202 | GlobeNewswire (Europe) | CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen | |
01.08.23 | Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 203 | GlobeNewswire (Europe) | CARLSBAD, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TELADOC HEALTH | 12,126 | -0,23 % | Why Teladoc Health Stock Dived on Friday | ||
NUGEN MEDICAL DEVICES | 0,077 | +0,52 % | NuGen Medical Devices Inc.: NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement | Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces that it has agreed to settle an aggregate of €275,000 of indebtedness... ► Artikel lesen | |
ORPEA | 12,582 | -0,66 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
ORGANON | 17,225 | -0,61 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 19.04.2024 | The following instruments on XETRA do have their last trading day on 19.04.2024.Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 19.04.2024.ISIN NameUS2310211063 Cummins Inc.US68622V1061 Organon... ► Artikel lesen | |
NANO-X IMAGING | 8,940 | +0,22 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
BUTTERFLY NETWORK | 0,780 | +10,56 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 12,230 | +1,24 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
CARMAT | 3,145 | -0,47 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
HYPERFINE | 0,845 | +1,68 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
MIMEDX | 6,265 | +0,32 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
BIOMERICA | 0,665 | -2,21 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
ATRION | 370,00 | -6,09 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen |